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Abstract: The implementation of Molecularly Imprinted Polymers (MIPs) into sensing systems
has been demonstrated abundantly over the past few decades. In this article, a novel application
for an MIP-based thermal sensing platform is introduced by using the sensor to characterize the
drug release kinetics of a nanoporous silver-organic framework. This Ag nanoporous matrix was
loaded with acetylsalicylic acid (aspirin) which was used as a model drug compound in this study.
The drug elution properties were studied by placing the nanoporous matrix in phosphate buffered
saline solution for two days and measuring the drug concentration at regular time intervals. To this
extent, an acrylamide-based MIP was synthesized that was able to detect aspirin in a specific and
selective manner. Rebinding of the template to the MIP was analyzed using a thermal sensor
platform. The results illustrate that the addition of aspirin into the sensing chamber leads to a
concentration-dependent increase in the phase shift of a thermal wave that propagates through the
MIP-coated sensor chip. After constructing a dose-response curve, this system was used to study
the drug release kinetics of the nanoporous matrix, clearly demonstrating that the metalorganic
framework releases the drug steadily over the course of the first hour, after which the concentration
reaches a plateau. These findings were further confirmed by UV–Visible spectroscopy, illustrating
a similar time-dependent release in the same concentration range, which demonstrates that the
MIP-based platform can indeed be used as a low-cost straightforward tool to assess the efficacy of
drug delivery systems in a lab environment.
Keywords: molecularly imprinted polymers; thermal detection; nanoporous matrix; drug delivery
1. Introduction
Molecular imprinting technology originally focused on the development of imprinted particles
that could be packed into columns for affinity separation, exploiting the affinity and selectivity
to extract a molecule of interest from complex matrices [1–3]. The concept was soon extended
by using molecularly imprinted polymers (MIPs) as antibody or enzyme mimics [4,5]. One of
the most interesting applications for MIPs is their incorporation into biomimetic sensing devices
as they mimic the affinity a natural receptor has for its target but are superior in terms of their
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chemical, thermal and long term stability [6–8] and can be made by way of a straightforward and
relatively low-cost synthesis process [9]. Although MIPs have been combined with optical [10,11],
electrochemical [12–15], microgravimetric [16,17] and thermal transducers [18–22] in devices with
great potential for e.g., diagnostic applications, the translation of these lab-based devices into
commercially available diagnostic sensors is still challenging due to difficulties with reproducibility,
integrated sampling and automated signal processing [23]. Therefore, this paper illustrates a new
potential application for MIP-based sensing systems, i.e., the study of the elution kinetics of drug
delivery systems.
Nanoporous matrices are macro-scale materials consisting of a large number of nano-scale
pores [24] giving the material a high adsorption capacity with favorable mechanical properties over
other types of nanomaterials [24]. As drug delivery systems, nanoporous materials are typically
utilized to control drug release rate with a wide variety of compounds investigated for this purpose to
date [25]. As with other types of nanostructured materials, the large amount of binding cavities can be
used to store drugs for steady release [26]. The solubility of drugs that poorly dissolve in water can
be regulated by carefully tuning the composition of the polymer and balancing the ratio of lipophilic
and hydrophilic segments [27]. Over the past ten years, nanoporous metal-organic frameworks have
emerged as an interesting class of nanomaterials due to their non-toxic nature and unusually large
loadings of a wide variety of drugs [28]. This type of material can therefore be considered to be a
suitable matrix for a drug delivery system. In addition, they can be synthesized without using organic
solvents and have shown to release drugs in a gradual and sustaining manner which can be tuned by
modifying the organic linkers within their binding cavities [29].
Drug elution kinetics from smart drug delivery systems are traditionally studied by measuring
the concentration of the drug in the medium surrounding the drug carrier. The drug concentration
in the elute is usually determined by classic laboratory devices/techniques including radioactive
assays [29], fluorescent resonance energy transfer [30], liquid chromatography [31] and UV–Visible
spectroscopy [32]. Although these methods are usually very sensitive and allow for a very
accurate determination of the drug concentration and hence the elution profile, most of them
require expensive readout devices, involve target labeling, or suffer from interference, limiting
their performance in complex media. Therefore, selective, label-free techniques have been studied
based on e.g., electrochemical [33] and microgravimetrical [34] readout methods. These platforms
allow for a straightforward and relatively fast analysis of the eluted medium but still require
ultrasensitive, expensive readout technology and conductive electrodes. In addition, data processing
and interpretation can be tricky and require some experience.
Therefore, we introduce an elegant MIP-based platform for studying drug elution from a
metal-organic framework in this article. Silver metalorganic frameworks were synthesized crosslinking
AgNO3 with ethylene diamine in sodium-hydroxide solution leading to a sponge-like structure
containing a wide distribution of nanometer sized cavities. These nanoporous matrixes were loaded
with the model drug, acetylsalicylic acid (aspirin), one of the drugs most abundantly used for the
treatment of pain, fever or inflammation that has also demonstrated to possess antithrombotic effects
which positively affects patients at risk for heart failure [35]. The drug elution under physiological
conditions was studied in the lab by applying aspirin-imprinted MIPs to aluminum electrodes and
studying the propagation of a thermal wave through the chip in function of an increasing concentration
of acetylsalicylic acid, a technique that was used successfully in previous work for the detection of
dopamine in banana juice [21]. Next, the constructed dose-response curve from this experiment
was used to determine the aspirin concentration in PBS solution containing drug eluted from the
nanoporous matrix. The results demonstrated that the nanoporous matrix releases the drugs in a
burst-like manner, releasing the drug in a constant fashion during the first two hours, after which
the concentration in the media surrounding the sponge remains stable. These results were validated
using UV–Visible spectroscopy, which shows a similar behavior and a similar concentration range,
illustrating the potential of the platform for drug elution studies.
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2. Materials and Methods
2.1. Chemicals
Acrylamide (AA), azobisisobutyronitrile (AIBN), polyvinylchloride (PVC) and silver nitrate
(AgNO3) were obtained from Sigma-Aldrich, Zwijndrecht, The Netherlands. Methanol absolute
and acetonitrile were bought at Biosolve B.V., Valkenswaard, The Netherlands. Acetone pure
(purity > 99.9%), sodium hydroxide, sulfuric acid, ethanol, salicylic acid and phosphate buffered saline
(PBS) tablets were acquired from VWR chemicals, Amsterdam, The Netherlands. Ethylenediamine
(EDA), hydrazine hydrate and ethylene glycol dimethacrylate (EGDM) were procured from Merck
Schuchardt OHG, Hohenbrunn, Germany. Polydimethysiloxane (PDMS) stamps were made with the
Sylgard 184 elastomer kit from Mavom NV, Schelle, Belgium. Aluminum chips were purchased at
Brico NV, Korbeek Lo, Belgium, and cut to the desired dimensions.
2.2. Instrumentation
Scanning electron microscopy (SEM) analysis of nanoporous matrices was performed with an
SEM (Philips XL 30, M4I, Maastricht University, Maastricht, The Netherlands), at an operating voltage
of 20 kV. Benchmarking with UV-Vis spectroscopy was done on a Shimadzu UV-3600 UV-VIS-NIR
spectrophotometer (Shimadzu Europe, Duisburg Germany). Grinding and sieving of bulk MIPs were
done using a Fritsch Planetary Micro Mill Pulverisette 7 premium line (VWR International, Amsterdam,
The Netherlands) and a Fritsch Analysette (VWR International, Amsterdam, The Netherlands) with a
20 µm mesh, respectively.
The thermal detection platform used for studying elution has been described thoroughly in
previous work [18–22]. Functionalized chips (MIP or NIP) were pressed mechanically with their
backside onto a copper block serving as a heat provider. The temperature of the copper underneath
the sample, T1, was monitored by a K-type thermocouple (TC Direct, Nederweert, The Netherlands).
This information was fed into a temperature control unit that stringently controlled T1 by modifying
the voltage over the power resistor (Farnell, Utrecht, The Netherlands) that heated the copper, using a
software-based (Labview, National Instruments, Austin, TX, USA) proportional-integral-derivative
(PID) controller (P = 10, I = 8, D = 0). The functionalized side of the chip faced a polyether ether
ketone (PEEK) flow cell which was sealed with an O-ring to avoid leakage, defining a contact area
of 28 mm2 and an inner volume of 110 µL. The flow cell was connected to a tubing system, allowing
the administration of liquids in a controlled and automated fashion by means of a syringe pump.
The temperature of the liquid inside the flow cell, T2, was measured by a second thermocouple, placed
1 mm above the chip. For each rebinding measurement the signal was stabilized in PBS at pH 7.4
which was used as to mimic physiological conditions.
2.3. Synthesis of the Silver Nanoporous Matrix
Nanoporous matrixes were synthesized by mixing aqueous AgNO3 (5 mL, 0.4 M, 2 mmol) with
aqueous NaOH (150 mL, 15 M, 2.25 mol). Crosslinking was initiated by the addition of aqueous EDA
(1.5 mL, 99% w/v, 0.25 mmol) and aqueous hydrazine hydrate (0.2 mL, 80% w/v, 5.0 mmol) to the
solution. The mixture was then purged with N2 and refluxed at 80 ◦C for 90 minutes with continuous
stirring at 1500 rpm. After cooling the reaction flask to room temperature, silver nanosponges were
isolated by vacuum filtration and air dried before being freeze dried for 6 hours. The resulting sponges
had a loading efficiency of 73.4% ± 5.6% and a corresponding loading capacity of 65.6% ± 2.9%.
2.4. Molecular Imprinting Procedure
Pre-polymerization mixtures composed of aspirin—(0.090 g, 0.5 mmol), AA (0.213 g,
3 mmol)—and EGDM—(3.00 mL, 98% w/v, 15 mmol)—were dissolved in acetonitrile (5 mL).
Polymerization was initiated by the addition of AIBN (0.025 g, 0.15 mmol) to the pre-polymerization
mixture. The mixture was sonicated for 10 min, then deoxygenated by purging with N2 for 5 min.
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It was then heated to 60 ◦C during 24 hours while shielding the mixture from light to prevent the
template from degrading. The resulting monolith was mechanically ground (700 rpm, 5 min, 10 mm
balls) and sieved for 4 with a 20 µm mesh. The resulting powder was extracted for 96 hours at 105 ◦C,
using a Soxhlet apparatus (VWR International, Amsterdam, The Netherlands) filled with a mixture of
methanol and ethanoic acid (7:3 v/v) in order to remove the template, aspiring, from the MIP. Finally,
the MIP particles were dried for three hours in an oven at 50 ◦C. Non-imprinted polymers (NIPs),
serving as a reference, were synthesized in the same manner without the presence of a template.
2.5. Chip Preparation
Polished aluminium plates were cut to obtain chips with the desired dimensions (10 × 10 mm2).
To immobilize MIP particles onto the surface of the measurement chip, a 100 nm PVC adhesive layer
(0.35 wt % PVC dissolved in tetrahydrofuran) was applied onto the chip by spin coating at 3000 rpm
for 60 s with an acceleration of 1100 rpm/s. MIP and NIP particles were stamped into this layer using
a PDMS substrate that was covered with a monolayer of polymer particles. The PVC layer was heated
for 2 h at a temperature of 100 ◦C—chosen specifically to be significantly above its glass transition
temperature (80 ◦C)—which allows beads to sink into the polymer layer. The samples were cooled
down prior to thermal measurements and any unbound particles were washed off with distilled water.
2.6. Loading of Nanoporous Matrixes with Aspirin
Aspirin was absorbed into the nanoporous matrixes by solvent evaporation. To this extent the
nanosponge (0.100 g, 1.85 mmol), was incubated with aspirin (0.26 g, 1.85 mmol) in ethanol (6.2 mL).
The mixture was shaken for 48 hours at 750 rpm. The solvent was removed under vacuum (30 ◦C,
300 mbar, 90 rpm) and dried at 65 ◦C for 3 h.
2.7. Drug Elution Analysis
Loaded nanoporous matrices (0.1 g) were incubated in 300 mL PBS (pH 7.4 at 37 ◦C) while gently
stirring at 100 rpm to mimic physiological conditions. Over the course of two days, 3 mL aliquots of
the PBS solution were taken at regular time intervals and the aspirin concentration was analyzed by
both thermal wave transfer analysis (TWTA) and UV–Visible spectroscopy to create an elution profile.
3. Results and Discussion
3.1. Surface Characterization of Ag Nanosponges
The Ag nanosponges were analyzed using scanning electron microscopy (SEM). This analysis,
shown in Figure 1, confirms that the metal-organic framework has a nanosponge structure containing a
large set of nano-sized cavities, providing a large a surface area that can be loaded with drug molecules.Polymers 2017, 9, 560  5 of 10 
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Figure 1. Surface analysis of an Ag-nanoporous matrix e using a scanning electron microscope at
magnification 2500×.
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3.2. Quantification of Aspirin in PBS
To assess whether it was possible to accurately determine the concentration of drug eluted from
the nanoporous matrix, a dose-response curve was constructed by exposing a MIP-coated chip to an
increasing concentration of aspirin in PBS. The thermal analysis clearly indicates that exposing the MIP
to aspirin in increasing concentrations results in a decrease of the liquid temperature inside the flow
chamber (Figure 2a) and an increase in the phase shift observed in the transmitted wave (Figure 2b).
The results in Figure 2b were used to construct a thermal Bode plot which shows the phase shift for
each transmitted frequency in function of the cummulative concentration of aspirin present in the flow
cell (Figure 2c). The error bars represent the maximum error observed on the measurement signal and
was calculated by comparing a programmed temperature ramp with the actual temperature profile.
Although the phase shift at every concentration is most pronounced at the highest input frequency, the
resolution appears to be optimal at 0.03 Hz. These findings are in line with previously obtained results
with dopamine MIPs in a similar setup [21]. The time-dependent TWTA data at 0.03 Hz were used to
construct a dose-response curve (Figure 2d), which will be used to assess the concentration of aspirin
that has eluted from the Ag-nanoporous matrix.
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and NIP were exposed to an increasing concentration of acetaminophen (paracetamol). The resulting
dose-response curves and the corresponding fits are shown in Figure 3.
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The results in Figure 3, illustrate that although the MIP is surprisingly selective in discriminating
between paracetamol and aspirin, the imprinting factor is small. This conclusion is in line with
previous findings with similar AA-based MIPs and can be explained by the fact that at a neutral pH,
not all binding sites and functional groups on the target will be protonated (pKa of aspirin is 3.49) [36].
Although previous work has indicated that the MIP would be more specific at acidic pH, the authors
decided to continue measuring at a pH of 7.4 to simulate drug elution in physiological conditions.
The results in Figure 2 indicate that the dose-response curve is highly usable and as the release pattern
will be studied in PBS no interference from other molecules is to be expected. However, if the concept
was extended to complex matrices in the future, the MIP synthesis route should be revised.
3.4. Thermal Analysis of Drug Elution
The elution of aspirin from the nanoporous matrixes was studied by incubating them in PBS and
retrieving a sample from the surrounding medium after 1, 10, 30, 120 and 360 minutes and after 48
hours. The elutions were diluted 5000 times with PBS to fit the linear range of the sensor. MIP-coated
electrodes were exposed to these diluted elutions and their response was summarized in a temperature
Bode plot (Figure 4a). The resulting phase shifts at 0.03 Hz were used to construct an elution profile
that was compared to the previously obtained dose response curve (Figure 4b) to determine the aspirin
concentration in each of the eluted samples.
The results obtained in Figure 4 were corrected for the dilution factor to create an elution profile.
To benchmark the results obtained with our platform, the results were validated using a gold standard,
relatively low-cost reference technique, i.e., UV–Visible spectroscopy/The elution profiles of both
techniques demonstrate a similar behavior (Figure 5a): a characteristic exponential release pattern
(fitted in Origin 8.0, Originlab, Northampton, MA, USA) which contains a sharp increase within the
first two hours after which a stable plateau is reached that does not significantly change over the next
two days. This indicates that the nanoporous matrix releases the drugs in a relatively quick burst which
Polymers 2017, 9, 560 7 of 10
is suitable for some applications requiring immediate effect. However, to actually achieve sustained,
prolonged delivery of drugs the nanoporous matrix should be functionalized with molecules that bind
the drug and actually release it slowly over time.
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over the next two days. This indicates that the nanoporous matrix releases the drugs in a relatively 
quick burst which is suitable for some applications requiring immediate effect. However, to actually 
achieve sustained, prolonged delivery of drugs the nanoporous matrix should be functionalized with 
molecules that bind the drug and actually release it slowly over time. 
When analyzing the elution profile obtained by UV–Visible spectroscopy, a small decrease in 
the concentration of aspirin can be observed over the course of two days, which leads to a distortion 
of the exponential fit. This can be explained by the fact that some of the acetylsalicylic acid will be 
converted into salicylic acid in PBS. This is confirmed by analyzing UV absorbance at 295.5 nm, which 
shows that salicylic acid is indeed present in the elution and its concentration will increase slightly 
over the course of two days (Figure 5b). The fact that this is not shown in the TWTA data is due to 
the fact that both compounds will bind to the MIP in a similar manner [36]. These data suggest that 
although the proposed sensor platform is not able to monitor the conversion of the drug to its 
metabolite, and is therefore less specific in this case, it is still a valuable alternative for the gold 
standard. Moreover, the application of UV–Visible spectroscopy for determining drug concentration 
in complex media can be troublesome due to the presence of other compounds that overlap the 
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Figure 4. Drug elution analysis. The drug elution was studied using thermal wave transfer analysis
(T TA) and the resulting Bode plot shows a concentration-dependent phase shift indicating that
the concentration of aspirin gradually increases with time (a). The dose-response curve was used to
determine the concentration in the eluted solutions (b).
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absorption spectrum of the drug under study [37]. The current platform on the other hand, has 
already proven to be capable of identifying small molec les in compl x edia such as blood plasma 
[38]. In addition, r c nt research has own that the MIP-based thermal etup could be integrated 
into catheter-based commercial sensi g devices hich would enable to study drug relea  in vivo 
which is not possible with the current state- f-the-art techniques [39]. 
Figure 5. Validation of TWTA data by UV–Visible spectroscopy. The drug elution profile derived 
from the TWTA data in F gure 4 wer  compared to the drug elution profile obtained with UV–Visible 
and b th how a initial burst of aspirin release in t e first two h urs in the milimolar regime ( ). The 
decre se in aspirin concentration for the UV–Visible data shown in Figure 5a can be explained by
conversion of aspirin into salicylic acid which is confirmed by analyzing absorbance at 295.5 nm (b). 
4. Conclusions 
The data shown in this article illustrate the potential use of a MIP-based thermal detection 
platform, which has previously been used for diagnostic purposes, for analyzing the drug release 
kinetics of drug delivery matrices. A proof-of-principle was demonstrated by validating the results 
obtained with the biomimetic sensor using UV–Visible spectroscopy, demonstrating a similar profile 
in the same concentration range. The metalorganic framework synthesized in this work appears to 
release the model drug, aspirin, within the first two hours limiting its pharmaceutical use at this 
point. Therefore, future research should be aimed at functionalizing the framework to get to a more 
gradual release of the drug. In addition, its release profile will be studied in a more realistic setting 
to mimic sink conditions and potential degradation of the matrix to fully understand the 
pharmaceutical potential of diverse drug delivery systems. The proposed platform could be a very 
versatile tool for these release studies by providing valuable information on the performance of the 
drug release system. This information can in turn be used as a feedback loop to fine-tune the drug 
release framework’s synthesis procedure to acquire drug release matrices with a high potential for 
pharmaceutical application. In addition, loading and elution of other, potentially more relevant drugs 
should also be studied in more challenging, biological media. As the MIP platform is generic, it can 
be used to study a wide variety of targets in a wide variety of matrices, by changing the MIP receptors 
or optimizing their selectivity or performance in more challenging media and chemical conditions 
(pH, temperature, etc.). 
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fro he T T data in Figur 4 were compared to the drug elu ion profile obtai ed with UV–Visible
and both show a initial burst of aspirin r le se in the first two hours in the milimolar r gime (a).
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When analyzing the elution profile obtained by UV–Visible spectroscopy, a small decrease in the
concentration of spirin can be observed ov r the cours of two days, which leads to a dist rtion of the
exponential fit. This can be explained by the fact that some of the acetylsalicylic acid will be converted
into salicylic acid in PBS. This is confirmed by analyzing UV absorbance at 295.5 nm, which shows
that salicylic acid is indeed present in the elution and its concentration will increase slightly over the
course of two days (Figure 5b). The fact that this is not sho n in the TWTA data is due to the fact that
both compounds will bind to the MIP in a similar manner [36]. These data suggest that although the
proposed sensor platform is not able to monitor the conversion of the drug to its metabolite, and is
therefore less specific in this case, it is still a valuable alternative for the gold standard. Moreover, the
application of UV–Visible spectroscopy for determining drug concentration in complex media can
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be troublesome due to the presence of other compounds that overlap the absorption spectrum of the
drug under study [37]. The current platform on the other hand, has already proven to be capable of
identifying small molecules in complex media such as blood plasma [38]. In addition, recent research
has shown that the MIP-based thermal setup could be integrated into catheter-based commercial
sensing devices which would enable to study drug release in vivo which is not possible with the
current state-of-the-art techniques [39].
4. Conclusions
The data shown in this article illustrate the potential use of a MIP-based thermal detection
platform, which has previously been used for diagnostic purposes, for analyzing the drug release
kinetics of drug delivery matrices. A proof-of-principle was demonstrated by validating the results
obtained with the biomimetic sensor using UV–Visible spectroscopy, demonstrating a similar profile
in the same concentration range. The metalorganic framework synthesized in this work appears
to release the model drug, aspirin, within the first two hours limiting its pharmaceutical use at
this point. Therefore, future research should be aimed at functionalizing the framework to get to a
more gradual release of the drug. In addition, its release profile will be studied in a more realistic
setting to mimic sink conditions and potential degradation of the matrix to fully understand the
pharmaceutical potential of diverse drug delivery systems. The proposed platform could be a very
versatile tool for these release studies by providing valuable information on the performance of the
drug release system. This information can in turn be used as a feedback loop to fine-tune the drug
release framework’s synthesis procedure to acquire drug release matrices with a high potential for
pharmaceutical application. In addition, loading and elution of other, potentially more relevant drugs
should also be studied in more challenging, biological media. As the MIP platform is generic, it can be
used to study a wide variety of targets in a wide variety of matrices, by changing the MIP receptors or
optimizing their selectivity or performance in more challenging media and chemical conditions (pH,
temperature, etc.).
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